PATENT CLAIM ANALYSIS

Application Number: 15892071
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides oligomeric compounds comprising at least one neutral methoxypropyl phosphonate modified internucleoside linkage. Such oligomeric compounds have one or more improved properties such as selectivity, potency, improved toxicity profile and or improved proinflammatory profile. Such oligomeric compounds have enhanced stability to exposure to base during synthesis. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.

Claim (Index 87):
The oligomeric compound of  claim 74  further comprising one 5\u2032 or 3\u2032-conjugate group.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.53731
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15305742', '14238094', '15305451', '15125634', '13864534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.74389777866658
- 35 USC 102 Novelty (BERT): 0.5487661228904956
- Combined Prediction Score: 0.7243846130889716
- Mean Citation Score: 359.867854
- Max Citation Score: 400.9201
- Similarity Product: 289.306690712893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test